Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Mimedx (MDXG) Return on Sales (2016 - 2025)

Mimedx (MDXG) has disclosed Return on Sales for 15 consecutive years, with 0.0% as the latest value for Q2 2025.

  • Quarterly Return on Sales changed 0.0% to 0.0% in Q2 2025 from the year-ago period, while the trailing twelve-month figure was 0.0% through Jun 2025, down 1.0% year-over-year, with the annual reading at 0.0% for FY2024, 3.0% up from the prior year.
  • Return on Sales hit 0.0% in Q2 2025 for Mimedx, down from 0.0% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.13% in Q4 2022 to a low of 0.18% in Q1 2022.
  • Historically, Return on Sales has averaged 0.04% across 5 years, with a median of 0.0% in 2023.
  • Biggest five-year swings in Return on Sales: increased 26bps in 2021 and later dropped -14bps in 2022.
  • Year by year, Return on Sales stood at 0.0% in 2021, then surged by 3275bps to 0.13% in 2022, then crashed by -81bps to 0.03% in 2023, then plummeted by -95bps to 0.0% in 2024, then plummeted by -51bps to 0.0% in 2025.
  • Business Quant data shows Return on Sales for MDXG at 0.0% in Q2 2025, 0.0% in Q1 2025, and 0.0% in Q4 2024.